In the BioHarmony Drug Report Database
Tecovirimat
Tpoxx (tecovirimat) is a small molecule pharmaceutical. Tecovirimat was first approved as Tpoxx on 2018-07-13. It is used to treat smallpox in the USA. Tpoxx’s patents are valid until 2031-03-23 (FDA).
Trade Name
|
Tpoxx |
|---|---|
Common Name
|
tecovirimat |
ChEMBL ID
|
CHEMBL1257073 |
Indication
|
smallpox |
Drug Class
|
Antivirals: antiviral, disrupts viral maturation |
Image (chem structure or protein)